ERC

ERC Consolidator Grants 2025

ERC-2026-CoGThese grants are open to researchers of any nationality with 7-12 years of experience since completing their doctorate.

ERC Consolidator Grants are designed to support outstanding Principal Investigators who are at a stage in their career where they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the innovative character, ambition and feasibility of their research proposal.

More information in this link.

Closing date: 13/01/2026

To support applications for these calls, the agency ERC has recorded the webinar on the basic concepts of the Work Programme (WP) 2026.

Cluster 1 Health – Single stage

Destination – Staying healthy in a rapidly changing society.

• HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioral interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people.

• HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioral interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people.

Destination – Living and working in a health-promoting environment

• HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health.

• HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems.

• HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research.

Destination – Tackling diseases and reducing disease burden

• HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults.

• HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions.

• HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential.

• HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximizing collaboration and coordination with sectors and in settings beyond the healthcare system (GACD).

• HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways.

• HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health.

Destination – Ensuring equal access to innovative, sustainable, and high-quality healthcare

• HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalized approaches.

• HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems.

Destination – Developing and using new tools, technologies and digital solutions for a healthy society

• HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing.

• HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine.

• HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices.

• HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centers of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs).

Destination – Maintaining an innovative, sustainable, and competitive EU health industry

• HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centered health technologies.

More Information

Closing date: 16/04/2026

ERA4Health

Trials4Health: Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases call

The European association ERA4Health has launched its seventh Joint Transnational Call (JTC 2026), Trials4Health, aimed at funding investigator-initiated multicenter clinical trials (IICS) in cardiovascular, autoimmune and metabolic diseases.

The objective is to support pragmatic randomized studies comparing the effectiveness and/or repurposing of drugs, promoting transnational collaboration between clinical and public health teams.

Learn more.

Pre-proposal closing date: 27/01/2026

Date of results of pre-proposals: 17/04/2026

Deadline for submitting complete proposals: 17/06/2026

ERA4Health

Prevent-OO: Understanding and Preventing Overweight and Obesity

The European association ERA4Health has launched its eighth Joint Transnational Call (JTC 2026), Prevent-OO, aimed at funding multinational collaborative research on the causes, complications and prevention of overweight and obesity.

The aim is to promote multidisciplinary and transnational projects that:

• Delve deeper into the biological mechanisms of obesity and its complications, and/or

• Develop public health strategies aimed at critical life transition stages, influenced by biological or socio-environmental changes.

Learn more.

Pre-proposal closing date: 21/01/2026

Date of results of pre-proposals: 13/04/2026

Deadline for submitting complete proposals: 10/06/2026

PerMed

EP PerMed: Research Innovation and Technology Call for Proposals (RITC) 2026

Test and Demonstration of Multimodal Data Approaches for Personalized Medicine (MultiPMData2026)

This call seeks to bring together companies and clinical stakeholders (healthcare providers, patients, and researchers) to test innovative solutions in controlled, real-world settings, with the goal of improving the management of multimorbidity.

EP PerMed will fund projects focused on the use of multimodal data to provide more efficient and personalized management for patients with at least two chronic diseases. Projects must test and develop mature solutions in real-world settings, adopt a systemic approach, and integrate six key elements (knowledge, technology, infrastructure, business models, policies, organization, and values). Proposals must include a clear strategy for multimodal health data management.

Consortia must have a clinical partner and at least one SME or industrial partner. Clinical studies can be funded, but not large clinical trials.

Closing date for the first phase: 12/01/2026

Closing date for the second phase: 27/04/2026

PerMed

EP PerMed: Personalized Medicine for CARdiovascular, MEtabolic, and kidney diseases (CARMEN2026)

The objective of this call is to fund transnational research projects in human health on innovative personalized medicine strategies for patients with cardiovascular, metabolic or renal diseases.

More Information

Closing date for the first phase: 10/02/2026

Closing date for the second phase: 09/06/2026

PerMed

EP PerMed Fast Track Validation Program 2026

Support to accelerate the validation and adoption of innovative personalized medicine solutions.

More Information

Closing date: 10/03/2026

BrainHealth

The European Association for Brain Health (EP Brain Health) will launch its first calls in 2026.

In early 2026, the European Association for Brain Health (EP Brain Health) will open its first two calls for multinational translational research projects.

Call 1: Biological, social and environmental factors that shape brain health throughout life – neurological, mental and sensory disorders.

Call 2: Biological, social and environmental factors that shape brain health throughout life – neurodegenerative disorders.

These calls will mark the start of a decade-long collaborative effort to advance understanding of brain health, drive innovation, and improve prevention, care, and the quality of life for millions of people in Europe and beyond.

Full details—including scope, participating funders, and eligibility rules—will be published in early December 2025.

More Information

OH AMR

Joint transnational call 2026: New treatments to tackle AMR

On November 18, the first joint transnational call for proposals was published. EUP OHAMR antimicrobial resistance partnershipentitled "Treatments and adherence to therapeutic protocols". The objective of this call is to improve therapeutic success rates in patients, animals and plants affected by bacterial or fungal infections, offering new treatment options and, at the same time, reducing the risk of resistance emerging in the different settings of the "One Health" approach.

The call is co-financed by the European Union and has the participation of 37 funding organizations from 28 countries, with a total estimated budget of over 31 million euros.

Also participating in this call, as national and regional funding bodies, are the Aragonese Institute of Health Sciences (IACS), the State Research Agency (AEI) and the Carlos III Health Institute (ISCIII).

Partner search tool available in this link

Closing date: 02/02/2026

Middle School

JTC 2026 - Access to Care

The European Association Transforming Health and Care Systems (THCS) has launched its fourth Joint Transnational Call (JTC 2026), aimed at funding research and innovation projects focused on ensuring equitable access to health and care services, as well as providing policymakers and decision-makers with the tools and evidence to implement an efficient redistribution of resources in transforming healthcare systems. This call involves 32 funding agencies, with an indicative budget of €35 million (In Spain: the Andalusian Regional Government's Ministry of Health and Consumer Affairs, the Marqués de Valdecilla Research Institute, and the Carlos III Health Institute).

The selected projects must propose innovative solutions that contribute to reducing inequalities in access to and use of health and care services, through new financial models, innovative service delivery models, and interdisciplinary integrated care programs.

More Information

Pre-proposal closing date: 02/02/2026

Closing date for complete proposals: 30/06/2026

ERDERA

ERDERA – Joint Transnational Call 2026

Resolving unsolved cases in rare genetic and non-genetic diseases

The European Rare Diseases Research Alliance (ERDERA) is launching its joint transnational call for proposals in December 2026, "Resolving unsolved cases in rare genetic and non-genetic diseases".

The call focuses on providing diagnostic clarity to cases of rare diseases, both genetic and non-genetic, that remain undiagnosed despite previous studies.

Areas of interest (examples):

• Identification and functional validation of variants of uncertain meaning.

• Integrated multi-omics approaches and advanced bioinformatics and AI tools.

• Modeling of disease mechanisms and use of clinical, environmental and sensor data.

More Information

Call for applications opens: 10/12/2026

Pre-proposal closing date: 12/02/2026

Deadline for submitting complete proposals: mid-2026 (June-July, according to the final text)

IHI

Pre-announcement: IHI Call 12 – Driving innovation for a competitive European health ecosystem

The European Innovative Health Initiative (IHI JU) has published draft topics for its upcoming IHI Call 12, an applicant-led call aligned with the Strategic Research and Innovation Agenda and the European Life Sciences Strategy. The call is structured around five themes focused on driving innovation in health:

• Understanding the determinants of health,

• Integration of fragmented R&D in health,

• Integrated and person-centered care,

• Digitization and data sharing in the healthcare sector, and

• Evaluation of the added value of innovative healthcare solutions.

Although the details of the call for proposals and its timeline are still pending official approval, interested organizations are encouraged to begin searching for partners and exploring cross-sector collaboration opportunities.

More information on the IHI website

EU4Health

EU4Health calls for proposals  

On behalf of the European Commission, HaDEA has published new open calls for proposals covering nine topics included in the EU4Health Work Programme and based on DGSANTE's policy priorities:

• EU4H-2026-SANTE-PJ-01: Call for proposals to pilot and implement gastric cancer screening programs (CR/CV&NCD-g-25-12)

• EU4H-2026-SANTE-PJ-02: Call for proposals to pilot and implement lung cancer screening programs (CR/CV&NCD-g-25-13)

• EU4H-2026-SANTE-PJ-03: Call for proposals to pilot and implement prostate cancer screening programs (CR/CV&NCD-g-25-14)

• EU4H-2026-SANTE-PJ-04 European flagship initiative leveraging AI and health data for cardiovascular health and related non-communicable diseases: advances in risk prediction, prevention, treatments, personalized care, and rehabilitation (CR/CV&NCD-g-25-16)

• EU4H-2026-SANTE-PJ-05: Call for proposals on lifelong prevention for healthy living, with a focus on cardiovascular disease (CR/CV&NCD-g-25-18)

• EU4H-2026-SANTE-PJ-06: Call for proposals to support the development of a price, reimbursement, and access monitoring system for medicines through the EURIPID database (HS-g-25-20)

• EU4H-2026-SANTE-PJ-07: Call for proposals for an orphan medical device program, specifically targeting pediatric patients (HS-g-25-24)

• EU4H-2026-SANTE-PJ-08Call for proposals on health data for biotechnology innovation, leveraging the European Health Data Area (DI-g-25-31)

• EU4H-2026-SANTE-PJ-09: Call for proposals to contribute to the organization of conferences (OA-g-25-33)

Closing date: 06/01/2026

• DIGITAL-2026-AI-09-DS-HEALTH-STORAGE: Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space

• DIGITAL-2026-AI-09-DS-HEALTH-TOOL: Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data tools. 03/03/2026

• DIGITAL-2026-AI-09-SOLUTIONS-CANCER-STEP: Deployment of cutting-edge multi-modal AI-based solutions in medical imaging.

Closing date: 03/03/2026

OTHER

CSL

CSL Research Acceleration Initiative 2026

This call for proposals aims to accelerate the discovery of innovative biotherapies through partnerships between CSL and global research organizations and companies. We are seeking innovative research projects that address unmet medical needs and align with CSL's therapeutic areas.

For more information, it is recommended to visit this link

Closing date for expression of interest: 12/12/2025

INTER-LOCAL

CSL Research Acceleration Initiative 2026

The INTER-LOCAL call for proposals is now open for its first edition, aiming to promote international multicenter clinical trials (phase II or III) focused on local treatments based on surgery or radiotherapy for rare cancers or cancers with low survival rates. The AECC Scientific Foundation, together with funding entities from Belgium, the Netherlands, Sweden, and Norway, seeks to support collaborative projects that improve treatment options for these patients.

Consortia with at least three participating funding countries may apply for funding; additional centers in other countries may be included to expedite recruitment. Proposals must originate from the academic or clinical field and require active patient participation in their design and implementation.

More Information

Closing date: 22/01/2026

09/12/2025

Informative Webinar – INTER-LOCAL Call for Proposals

This informative webinar will be dedicated to guiding potential applicants to the INTER-LOCAL call for proposals. The session will offer an overview of the scope, objectives, eligibility, and budget structure, as well as recommendations for preparing a competitive proposal and a live Q&A session with the program team.

Aimed at: researchers interested in presenting multinational clinical trials in rare or difficult-to-treat cancers.

Registration: send an email to inter-local@kwf.nlAfter registration, the link to access the webinar will be provided.

10/12/2025

JTC 2026 Information Webinar – THCS Access to Car0

The European Partnership for the Transformation of Health and Care Systems (THCS) is organizing an information webinar aimed at potential applicants for its fourth joint transnational call “Access to Care”, which was officially launched on 21 November 2025.

The aim of the meeting is to provide practical information on the content of the call, its objectives and the process for submitting proposals, within the framework of the European effort to coordinate and promote research and innovation in the transformation of health and care systems.

Registration

10/12/2025

Information session: Funding opportunities in the field of biomedicine and health 2026

As every year-end, the ISCIII holds an information day, in collaboration with FECYT, about funding opportunities in Horizon Europe in 2026 in the field of biomedicine and health.

Among other issues, the general aspects of European programs, the 2026-2027 work program of the health cluster, the calls for European health partnerships and recommendations for preparing proposals in international collaboration projects will be explained.

Registration

11/12/2025

EATRIS Digital Symposium on AI in ATMP

Development and Immune monitoring

The European infrastructure EATRIS is organizing a virtual symposium focused on the use of artificial intelligence in the development of advanced therapy medicinal products (ATMPs) and in the monitoring of the immune system.

The meeting will bring together experts and members of the EATRIS community to share progress, foster collaborations, and explore new opportunities for innovation.

Registration

16/12/2025

EP PerMed JTC2026 CARMEN2026 – Information Day (online)

EP PerMed is organizing an online information session on the Joint Transnational Call 2026 CARMEN2026 (personalized medicine in cardiovascular, metabolic and renal diseases) on 12/16 from 10:00-12:00.

The event will feature:

• Scientific scope of the call and planned topics.

• Consortium eligibility rules and requirements.

• Detailed schedule (pre-proposal and full proposal).

Registration

16/12/2025

ERDERA Joint Transnational Call 2026 – Information Webinar (online)

ERDERA will hold a free information webinar to present JTC 2026 “Resolving unsolved cases in rare genetic and non-genetic diseases” on 16/12 at 15:00–17:00.

Webinar content:

• Presentation of the ERDERA partnership and its support services.

• Scope, eligibility criteria, and call schedule.

• Recommendations on the involvement of patient organizations and the One Health approach where appropriate.

Registration

19-20/01/2026

IHI Curious about Call 12? Join its info webinars!

The Innovative Health Initiative (IHI) will hold its IHI Call Days for Call 12 on January 19 and 20, 2026, in an online format. These webinars will provide key information about the call: financial aspects, participation guidelines, procedures, and general guidance for preparing competitive proposals.

The IHI 12 call invites innovative projects that address key health challenges in Europe and respond to patient needs, in line with IHI's Strategic Research and Innovation Agenda (SRIA). This is a single-stage call, meaning that proposals must guarantee that at least 50% of project costs are covered by in-kind contributions from IHI's industry members and, where applicable, contributing partners.

Registration

20/01/2026

Horizon Europe info days – EU Missions – Cancer

On January 20, 2026, the European Commission will organize Info Days dedicated to Horizon Europe Missions for the upcoming 2026 calls for proposals. In a 100% online format, funding opportunities linked to all European missions, including the Cancer mission, will be presented.

Participation offers an excellent opportunity to learn in detail about the thematic challenges, the rules of participation and cross-cutting synergies, as well as to advance the planning of international collaborative proposals.

More information and registration coming soon at the following link link

20/01/2026

Introductory Webinar EP PerMed Fast Track Validation Program 2026

A webinar to review the EP PerMed Fast Track 2026 Call and answer any questions about the call, the application process or the project.

More information and registration coming soon at the following link link

26-30/01/2026

Cluster Health Horizon Europe Brokerage Event 2026

From January 26 to 30, 2026, the Horizon Europe Health Cluster Brokerage Event will take place, organized by HNN 3.0, the European Commission, and the Enterprise Europe Network. This event aims to facilitate the creation of consortia for the 2026 calls of the 2026-2027 Health Work Programme. This international meeting, held before the Cluster Health INFODAY on February 10, 2026, gives interested parties more time to identify partners and prepare competitive proposals.

The event is free, but requires registration and profile activation, including at least one collaboration offer or request in the Marketplace section, aligned with the topics of interest. Registration must be completed in English, and profile validation may require adjustments requested by the organizers.

Target audience: entities eligible for Horizon Europe (universities, research centers, companies, hospitals, public administrations, NGOs, patient associations, etc.).

Registration

10/02/2026

Webinar Cluster 1 Health INFODAY 2026 (European Commission)

Virtual information session on Horizon Europe – Cluster 1 Health, where the European Commission will present the 2026 topics of the 2026–2027 Work Programme. The scientific and technical content of the calls for proposals, the rules for participation and evaluation, and a Q&A session will be held. Time: 08:00–16:00 CET.

More Information